By Route of Administration

Other Routes (IM, Intrathecal, Nasal) Market Analysis

Cross-industry research covering Other Routes (IM, Intrathecal, Nasal) across 1 market reportspanning Pharmaceuticals.

1 Reports
1 Industries

Reports Covering Other Routes (IM, Intrathecal, Nasal)

Hospital Acquired Infection Control Market to Reach USD 41.6B by 2033 at 6.4% CAGR

Pharmaceuticals·Market: USD 25.3 Billion (2025)·CAGR: 6.4%

Long-acting intramuscular formulations, including cabotegravir in HIV-positive inpatient contexts (nct:NCT06518408), and intrathecal antibiotics in CNS HAI round out this segment with limited but stable volume.

5%

Market Share

5.0%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments